
Adjuvant Opdivo Combo Improves Survival Outcomes in Advanced Head and Neck Cancer
Among patients who are at high risk of relapse with locally advanced squamous cell carcinoma of the head and neck, adjuvant Opdivo (nivolumab) with cisplatin and radiotherapy significantly improved disease-free survival compared with other treatments, …